Epigenetic inactivation of TFPI-2 as a common mechanism associated with growth and invasion of pancreatic ductal adenocarcinoma. - Wikidata - awgldk - TriplyDB

Epigenetic inactivation of TFPI-2 as a common mechanism associated with growth and invasion of pancreatic ductal adenocarcinoma.

Epigenetic inactivation of TFPI-2 as a common mechanism associated with growth and invasion of pancreatic ductal adenocarcinoma.

http://www.wikidata.org/entity/Q40481644

about

Ovarian cancer, the coagulation pathway, and inflammation Genome-wide profiling of methylated promoters in pancreatic adenocarcinoma.Cyclooxygenase-deficient pancreatic cancer cells use exogenous sources of prostaglandins.Genome-wide analysis of promoter methylation associated with gene expression profile in pancreatic adenocarcinoma.Genome-wide CpG island profiling of intraductal papillary mucinous neoplasms of the pancreas.Tissue factor pathway inhibitor-2 was repressed by CpG hypermethylation through inhibition of KLF6 binding in highly invasive breast cancer cells DNA methyltransferases: a novel target for prevention and therapy.TFPI-2 is a putative tumor suppressor gene frequently inactivated by promoter hypermethylation in nasopharyngeal carcinoma.Leukocyte DNA methylation signature differentiates pancreatic cancer patients from healthy controls Molecular signatures of pancreatic cancer.Molecular pathology of intraductal papillary mucinous neoplasms of the pancreas.Effects of tissue factor pathway inhibitor-2 expression on biological behavior of BeWo and JEG-3 cell lines.Promoter hypermethylation and silencing of tissue factor pathway inhibitor-2 in oral squamous cell carcinoma.Evidence for the importance of personalized molecular profiling in pancreatic cancer.Low expression of TFPI-2 associated with poor survival outcome in patients with breast cancer Methylation of TFPI2 in stool DNA: a potential novel biomarker for the detection of colorectal cancer Reduction of pancreatic acinar cell tumor multiplicity in Dnmt1 hypomorphic mice.Identification of a human TFPI-2 splice variant that is upregulated in human tumor tissues.Clinical Significance of Tissue Factor Pathway Inhibitor 2, a Serum Biomarker Candidate for Ovarian Clear Cell Carcinoma.Tissue Factor Pathway Inhibitor-2 Gene Polymorphisms Associate With Coronary Atherosclerosis in Chinese Population.Unlike pancreatic cancer cells pancreatic cancer associated fibroblasts display minimal gene induction after 5-aza-2'-deoxycytidine.Integrated genome-wide analysis of genomic changes and gene regulation in human adrenocortical tissue samples.Identifying molecular markers for the early detection of pancreatic neoplasia.Different mutant/wild-type p53 combinations cause a spectrum of increased invasive potential in nonmalignant immortalized human mammary epithelial cells Amplification of EMSY gene in a subset of sporadic pancreatic adenocarcinomas Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.DNA-intercalators causing rapid re-expression of methylated and silenced genes in cancer cells Epigenetics and epigenetic alterations in pancreatic cancer.Beneficial role of overexpression of TFPI-2 on tumour progression in human small cell lung cancer.Expression of a large LINE-1-driven antisense RNA is linked to epigenetic silencing of the metastasis suppressor gene TFPI-2 in cancer.Genetic and epigenetic alterations of familial pancreatic cancers.Multiple genes are hypermethylated in intraductal papillary mucinous neoplasms of the pancreas.Field Cancerization in Sporadic Colon Cancer.Genetic and epigenetic marker-based DNA test of stool is a promising approach for colorectal cancer screening.MicroRNA-148b and microRNA-152 reactivate tumor suppressor genes through suppression of DNA methyltransferase-1 gene in pancreatic cancer cell lines.Decoupling of DNA methylation and activity of intergenic LINE-1 promoters in colorectal cancer.Neuronal pentraxin II (NPTX2) is frequently down-regulated by promoter hypermethylation in pancreatic cancers.Diagnostic utility of aberrant methylation of tissue factor pathway inhibitor 2 in pure pancreatic juice for pancreatic carcinoma.Predicting the Grade of Dysplasia of Pancreatic Cystic Neoplasms Using Cyst Fluid DNA Methylation Markers.Methylation of tissue factor pathway inhibitor 2 as a prognostic biomarker for hepatocellular carcinoma after hepatectomy.

P2860

Q24816796-6BA047CB-0A57-40D8-8C03-89C903729788 Q30491042-FAC2D59F-3016-43CD-81EB-58E480FE087D Q30494961-21903E41-D622-4268-9C66-76DB0248D2D2 Q30502257-D7F15CCD-F959-42CC-912A-08462CD1FC8D Q30504615-3D834B6B-CA03-40FD-BB09-321B35B108A0 Q33308310-0312E606-18B2-43EB-A69E-799C0690F4E2 Q33579896-16FF1010-A0E5-49B0-9663-DE99EA74DBB4 Q33742715-626F2108-B858-4ED7-B810-1BE396BD9717 Q33859463-8BF48F3E-AA02-4356-B20E-E052F8E242BA Q33918801-ECD974DC-89EC-40B7-A7A4-C27D622D0751 Q34008627-F5941AAF-F767-42EA-A1A6-59F2CDA33505 Q34112769-FCC2852D-26BD-4DF7-9851-497F7E0D82C6 Q34161719-C7F1F366-65F2-4BFF-A6FD-04CC355EDA6C Q34387784-D6B1CC21-A087-4939-A941-4328382BA2C2 Q34623032-ED9D77E7-9B86-47E1-98DE-5FE8EB1ED04C Q34706624-51602D76-0969-4F1C-A876-E7CC36DB3E63 Q35020444-6CA22F8F-0F43-42E5-81D5-A1807E49239A Q35688507-191DDAE3-2953-4DA2-9A32-06C1CC25DA11 Q36178605-395EFEA9-374A-4EA8-94D8-991999157A8A Q36207118-1D9F1B24-CE35-46E9-AD2C-1DC722ED5C2D Q36226867-6AC942BB-D557-41C3-B9F8-453D93675669 Q36228058-0DFAD31A-3DA7-4DA9-962F-B5E7B5A6CC62 Q36328508-3E070FEC-72FF-4494-B731-10148314F9FF Q36640204-6388D067-8EAF-4CA2-96A4-850B25BEA351 Q36784879-FD6F6D72-8CF7-4514-9A5A-C6D84DCBC83A Q36801625-C6DD982A-11A4-4812-AA78-40F4381ACA09 Q37016577-2405BCD2-C778-4F50-A4AE-B33E56113847 Q37041763-AEFF197F-6F37-425D-8E1A-3DD1D9DA2DAB Q37043566-A49C3378-9CC0-4259-958E-70DB68C0EAF4 Q37080366-9D4F7BBD-7814-4A1E-B8FA-2D879F613780 Q37148201-740EED7E-ED73-46FF-B824-AB67450B8B86 Q37183611-94A39790-B49D-4692-9632-83221CF75F97 Q37213553-56F2A6CD-73C5-43EF-9157-A715E5D60324 Q37536997-491BD8FD-5A74-42C2-8409-EF64C1D7BFAA Q37692456-390E40FE-668C-4799-9C6D-FD80B91E8EBA Q38903814-A60A17CB-9733-42C4-B35F-C2E7D7CDCCB8 Q39312968-2A479CA6-9D68-473F-BBDE-CA2211F7A78C Q40233356-A6A45AD1-7893-4F25-B569-97CE1D4CBE34 Q40440052-9DC9241E-4A55-4682-9C1A-019CBCD3D4EA Q41447190-5B8A8CB6-979A-4E1D-BBDF-A4BE31F08C2F

P2860

Epigenetic inactivation of TFPI-2 as a common mechanism associated with growth and invasion of pancreatic ductal adenocarcinoma.

http://www.wikidata.org/entity/Q40481644

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh

2005年學術文章

@zh-hant

name

Epigenetic inactivation of TFP ...... creatic ductal adenocarcinoma.

@en

type

label

Epigenetic inactivation of TFP ...... creatic ductal adenocarcinoma.

@en

prefLabel

Epigenetic inactivation of TFP ...... creatic ductal adenocarcinoma.

@en

P1433

Q40481644-C298EF5F-D529-4975-AE71-E94163AD710F

P1476

Q40481644-BAA477E8-BA2E-41EE-A780-77374305BD62

P2093

Q40481644-01D5354C-F077-4A67-AED7-3E120EE4D699

Q40481644-668F9B3E-D7E8-4529-8A07-A9D45A1D726B

Q40481644-BA6CAC04-4C1F-4B6D-AF0A-A79368B5FEDC

Q40481644-D6EAF7D9-BBC2-4A5C-B07A-D61992B94A18

Q40481644-EF0DE93C-3CFB-4AB9-9452-0244862A3C0D

P2860

Q40481644-0050AD18-E51D-41A5-9E21-E1BAE6098F3A

Q40481644-049FEE7A-EFB9-4F5E-AACE-01F32AF7D7CA

Q40481644-05D33B32-1C42-4011-AAC4-16CCC7C1D5A8

Q40481644-08184DF6-8B36-4F49-AD09-441983D82AA8

Q40481644-10BE4B5D-B494-4957-8524-5833BC5C47CD

Q40481644-22FC7848-BB4E-46DB-AA17-753BCFAECE42

Q40481644-3035913C-13AF-4990-9C6F-FE3E4EC512F3

Q40481644-31D55A7F-22CC-4C8B-B063-93C9225027A2

Q40481644-31DC226B-4B7D-4797-A3F4-33372E3E2D9D

Q40481644-35686600-CAC4-4AA3-B4D0-8FBBC3311976

P2888

Q40481644-CEAA5C12-2BB1-4A3D-88EF-03AA0644E1D1

P304

Q40481644-44647D88-15A4-4522-8A3D-6DFCD6DA08C6

P31

Q40481644-A4A5FB48-80CE-4789-9A5D-F21BBD1768FC

P356

Q40481644-4EBDC4F5-1C79-422A-968E-CA29E553380D

P407

Q40481644-5180F95E-8322-48B8-A6E2-66C9ECAB7501

P433

Q40481644-1F4F74A0-3BA6-4F0E-8C32-D0CB1AAC43C5

P478

Q40481644-05DA329F-F348-4BBC-A306-81CFE74FE469

P50

Q40481644-2C82030F-8E96-4A22-98FF-1C162B694429

Q40481644-E91A508B-8F28-405F-891B-BFBD0EA12B9B

P577

Q40481644-D382AAD4-B910-4B02-A7E2-DA5AADDDABD1

P5875

Q40481644-8D5EC0E1-3F91-4815-94A7-59642C9652CE

P6179

Q40481644-675C2800-7F9A-446B-9B6E-40DCB7121359

P698

Q40481644-F2E39C25-B818-4599-9B17-681A9C460262

P921

Q40481644-CA2A6434-83B8-4AAC-99AE-79E35913EE88

P356

P1433

P1476

Epigenetic inactivation of TFP ...... creatic ductal adenocarcinoma.

@en

P2093

Antony R Parker

http://www.w3.org/2001/XMLSchema#string

James R Eshleman

http://www.w3.org/2001/XMLSchema#string

Norihiro Sato

http://www.w3.org/2001/XMLSchema#string

Noriyoshi Fukushima

http://www.w3.org/2001/XMLSchema#string

Yohei Miyagi

http://www.w3.org/2001/XMLSchema#string

P2860

Comprehensive analysis of CpG islands in human chromosomes 21 and 22

Molecular cloning, expression, and partial characterization of a second human tissue-factor-pathway inhibitor

Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands

DNMT1 and DNMT3b cooperate to silence genes in human cancer cells

Methyltransferase recruitment and DNA hypermethylation of target promoters by an oncogenic transcription factor

Tissue factor pathway inhibitor-2 suppresses the production of active matrix metalloproteinase-2 and is down-regulated in cells harboring activated ras oncogenes.

Matrix metalloproteinases: a tail of a frog that became a prince.

Invasion and metastasis in pancreatic cancer.

AGA technical review on the epidemiology, diagnosis, and treatment of pancreatic ductal adenocarcinoma. American Gastroenterological Association.

Tissue factor pathway inhibitor-2 is a novel mitogen for vascular smooth muscle cells.

P2888

P304

850-858

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.ONC.1208050

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

24

http://www.w3.org/2001/XMLSchema#string

P50

Christine A Iacobuzio-Donahue

Michael Goggins

P577

2005-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8134757

http://www.w3.org/2001/XMLSchema#string

P6179

1016657224

http://www.w3.org/2001/XMLSchema#string

P698

15592528

http://www.w3.org/2001/XMLSchema#string

P921